EyePoint (EYPT) Goodwill & Intangibles (2011 - 2022)
EyePoint (EYPT) reported Goodwill & Intangibles of $47.6 million for Q4 2022, down 30.3% on a YoY basis from $68.3 million in Q4 2021, and down 30.3% sequentially from $68.3 million in Q3 2022.
EyePoint (EYPT) Goodwill & Intangibles (2011 - 2022) Analysis & Trends
EyePoint (EYPT) has 12 years of Goodwill & Intangibles data on file, last reported at $47.6 million in Q4 2022.
- For the quarter ending Q4 2022, Goodwill & Intangibles fell 30.3% year-over-year to $47.6 million; the trailing twelve-month figure through Dec 2022 stood at $47.6 million (down 30.3% YoY), and the FY2022 full-year result was $47.6 million, down 30.3% from the prior year.
- Goodwill & Intangibles eased to $47.6 million in Q4 2022, from $68.3 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $68.3 million in Q2 2018 to a low of $21.5 million in Q2 2022.
- A 5-year average of $58.7 million and a median of $68.3 million in 2018 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles surged 5820.93% in 2018 and plunged 68.5% in 2022, its largest moves.
- Tracing EYPT's Goodwill & Intangibles over 5 years: stood at $68.3 million in 2018, then changed by 0.0% to $68.3 million in 2019, then changed by 0.0% to $68.3 million in 2020, then changed by 0.0% to $68.3 million in 2021, then tumbled by 30.3% to $47.6 million in 2022.
- Business Quant data shows EYPT's Goodwill & Intangibles at $47.6 million in Q4 2022, $68.3 million in Q3 2022, and $21.5 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | EyePoint | 1.07 Mn | -221.47 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 47.62 Mn |
| Sep 30, 2022 | 68.32 Mn |
| Jun 30, 2022 | 21.52 Mn |
| Mar 31, 2022 | 22.13 Mn |
| Dec 31, 2021 | 68.32 Mn |
| Sep 30, 2021 | 68.32 Mn |
| Jun 30, 2021 | 68.32 Mn |
| Mar 31, 2021 | 68.32 Mn |
| Dec 31, 2020 | 68.32 Mn |
| Sep 30, 2020 | 25.82 Mn |
| Jun 30, 2020 | 68.32 Mn |
| Mar 31, 2020 | 68.32 Mn |
| Dec 31, 2019 | 68.32 Mn |
| Sep 30, 2019 | 68.32 Mn |
| Jun 30, 2019 | 68.32 Mn |
| Mar 31, 2019 | 68.32 Mn |
| Dec 31, 2018 | 68.32 Mn |
| Sep 30, 2018 | 68.32 Mn |
| Jun 30, 2018 | 68.32 Mn |
| Mar 31, 2018 | 31.97 Mn |